Log In
Print this Print this

mGluR4 PAM (PXT002331) (formerly DT1687)

  Manage Alerts
Collapse Summary General Information
Company Domain Therapeutics S.A.
DescriptionSmall molecule positive allosteric modulator (PAM) of metabotropic glutamate receptor subtype 4 (mGluR4; GRM4)
Molecular Target Metabotropic glutamate receptor subtype 4 (mGluR4) (GRM4)
Mechanism of ActionMetabotropic glutamate receptor (mGluR) modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat Parkinson's disease (PD)
Regulatory Designation
PartnerPrexton Therapeutics S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today